About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ACRX - AcelRx Pharmaceutica...| Previous Close | $1.94 | Open | $1.89 |
| Volume | 2.58M | Market Cap | 175.53M |
| Yield | Last Dividend |
| AcelRx Announces an Investigator-Initiat... | 02/17/21 |
| REDWOOD CITY, Calif., Feb. 17, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused ... | |
| STAT+: FDA warns AcelRx of misleading ad... | 02/16/21 |
| The FDA warned that messaging from AcelRx Pharmaceuticals failed to convey ???potentially life-threatening risks" associated with Dsuvia. | |
| AcelRx Pharmaceuticals : Announces Prici... | 01/20/21 |
| REDWOOD CITY, Calif., Jan. 20, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and c... | |
| AcelRx Announces Pricing of $27.5 Millio... | 01/20/21 |
| REDWOOD CITY, Calif., Jan. 20, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused o... | |
| AcelRx Announces Underwritten Public Off... | 01/19/21 |
| REDWOOD CITY, Calif., Jan. 19, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused o... | |
| AcelRx Announces an Investigator-Initiat... | 01/19/21 |
| REDWOOD CITY, Calif., Jan. 19, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused ... | |
| Are You Following Analysts On These Penn... | 01/15/21 |
| This year has gotten off to a strong start already. Many stocks, including penny stocks , are reaching new 52-week and all-time highs. Meanwhile, the ... | |
| The Daily Biotech Pulse: Bausch Health I... | 01/13/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) Abb... | |
| AcelRx Pharmaceuticals Announces Publica... | 12/10/20 |
| REDWOOD CITY, Calif., Dec. 10, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the dev... | |
| AcelRx Pharmaceuticals Announces Partner... | 12/04/20 |
| REDWOOD CITY, Calif., Dec. 4, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the deve... | |
| AcelRx Pharmaceuticals Announces Comment... | 11/18/20 |
| REDWOOD CITY, Calif., Nov. 18, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the dev... | |
| AcelRx Pharmaceuticals Reports Third Qua... | 11/05/20 |
| REDWOOD CITY, Calif., Nov. 5, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused o... | |
| AcelRx to Host Third Quarter 2020 Financ... | 10/29/20 |
| REDWOOD CITY, Calif., Oct. 29, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced t... | |
| AcelRx Pharmaceuticals (NASDAQ:ACRX) Tra... | 10/22/20 |
| Shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) were up 9.5% during mid-day trading on Thursday . The stock traded as high as $1.90 and last trad... | |
| Pain Management- New Discoveries And Tre... | 10/01/20 |
| The research report on Pain Management Market provides a comprehensive analysis of the market status and development trend, including types, applicati... | |
| AcelRx to Host Virtual KOL Event on Peri... | 09/29/20 |
| REDWOOD CITY, Calif., Sept. 29, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused... | |
| AcelRx awarded ~$3.6M contract for DSUVI... | 09/22/20 |
| AcelRx Pharmaceuticals (ACRX +1.9%) has been awarded an initial contract of up to ~$3.6M for the purchase of DSUVIA to support a study to aid the deve... | |
| AcelRx Announces DSUVIA?? Added to the U... | 09/14/20 |
| REDWOOD CITY, Calif., Sept. 14, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused... | |
| AcelRx Announces an Investigator-Initiat... | 08/24/20 |
| REDWOOD CITY, Calif., Aug. 24, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused ... | |
| AcelRx Pharmaceuticals Reports Second Qu... | 08/10/20 |
| REDWOOD CITY, Calif., Aug. 10, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused ... | |
| AcelRx to Host Second Quarter 2020 Finan... | 08/03/20 |
| REDWOOD CITY, Calif., Aug. 3, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced th... | |
| AcelRx inks deal with Zimmer Biomet to d... | 07/23/20 |
| Zimmer Biomet's (NYSE:ZBH) Dental division has agreed to distribute AcelRx Pharmaceuticals' (NASDAQ:ACRX) Dsuvia (sufentanil sublingual tablet) within... | |
| AcelRx Pharmaceuticals : Announces Exclu... | 07/23/20 |
| REDWOOD CITY, Calif., July 23, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company, today announced an agreement to... | |
| AcelRx Announces $10 Million Common Stoc... | 07/23/20 |
| REDWOOD CITY, Calif., July 23, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) (AcelRx), a specialty pharmaceutical company focused on... | |
| La Jolla Pharmaceutical Rekindles Intere... | 06/22/20 |
| The bidding war for Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) seems to be far from over. What Happened: Tetraphase announced Monday that La Jolla... | |
| The Daily Biotech Pulse: Keytruda Setbac... | 06/10/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Dr.R... | |
| The Daily Biotech Pulse: Positive Readou... | 06/04/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peak (Biotech Stocks Hitting 52-week Highs June 3) Arena... | |
| Tetraphase Announces Receipt of Amended ... | 05/27/20 |
| WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel te... | |
| Tetraphase Announces Amendment to Merger... | 05/27/20 |
| WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel te... | |
| AcelRx Pharmaceuticals Reports First Qua... | 05/11/20 |
| REDWOOD CITY, Calif., May 11, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused o... | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Option Superstars | James Catzen | 76.00 % | Subscribe |
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 70.00 % | Follow |
| Biotech picks | mr jackson | 50.00 % | Follow |
| Biotech | Sajjadul Kibria | 50.00 % | Follow |
| R R Investments | Roland Van Rij | 45.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
